CrossrefInfokarte
Tislelizumab-induced hyperamylasemia: Case report and safety analysis using the FAERS database
Int. Journal of Clinical Pharmacology and Therapeutics · 2026-11-01 · 64 (11) · 623-631
DOI: 10.5414/cp204996 ↗Abstract
Kein Abstract verfügbar.
EUVIMED